Brand Name: Ancor Plus 2.5
Manufacturer: Aristopharma Limited.
Indication
Ancor Plus is indicated for the management of hypertension.
Dosage & Administration
The initial dose is 2.5 mg/6.25 mg once daily. Subsequent titration (14 day intervals) may be carried out with Ancor Plus tablets up to the maximum recommended dose 20 mg/12.5 mg once daily, as appropriate.
Therapy Guided by Clinical Effect: A patient whose blood pressure is not adequately controlled with 2.5-20 mg Bisoprolol daily may instead be given Ancor Plus. Patients whose blood pressures are adequately controlled with 50 mg of Hydrochlorothiazide daily, but who experience significant potassium loss with this regimen, may achieve similar blood pressure control without electrolyte disturbance if they are switched to Ancor Plus.
Replacement Therapy: The combination may be substituted for the titrated individual components.
Cessation of Therapy: If withdrawal of Ancor Plus therapy is planned, it should be achieved gradually over a period of about 2 weeks. Patients should be carefully observed.
Side effects
Generally well-tolerated. Most side effects are mild and transient. The common side effects fatigue, dizziness, headache, bradycardia, peripheral ischemia, palpitations, rhythm disturbances, claudication, orthostatic hypotension, diarrhoea, constipation, nausea, dyspepsia, rhinitis, pharyngitis etc.
Drug interaction
This combination drug may potentiate the action of other antihypertensive agents when used concomitantly. This combination drug should not be combined with other beta-blocking agents. Patients receiving catecholamine-depleting drugs, such as reserpine or guanethidine, should be closely monitored because the added beta-adrenergic blocking action of Bisoprolol may produce excessive reduction of sympathetic activity. This combination should be used with caution when myocardial depressants or inhibitors of AV conduction, such as certain calcium antagonists verapamil and benzothiazepine diltiazem classes or anti-arrhythmic agents, such as disopyramide, are used concurrently. Both digitalis glycosides and beta-blockers slow atrioventricular conduction and decrease heart rate.
Reviews
There are no reviews yet.